According to GeneDx Holdings's latest financial reports the company's current EPS (TTM) is -$35.56. In 2022 the company made an earnings per share (EPS) of -$54.40 a decrease over its 2021 EPS that were of -$32.25.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$35.56 | -34.63% |
2022 | -$54.40 | 68.68% |
2021 | -$32.25 |